Alpha-T-catenin is expressed in peripheral nerves as a constituent of Schwann cell adherens junctions.
Anthea WengErik E RabinAnnette S FlozakSergio E ChiarellaRaul Piseaux AillonCara J GottardiPublished in: Biology open (2022)
The adherens junction component, alpha-T-catenin (aTcat) is an established contributor to cardiomyocyte junction structure and function, but recent genomic studies link CTNNA3 polymorphisms to diseases with no clear cardiac underpinning, including asthma, autism and multiple sclerosis, suggesting causal contributions from a different cell-type. We show Ctnna3 mRNA is highly expressed in peripheral nerves (e.g., vagus and sciatic), where aTcat protein enriches at paranodes and myelin incisure adherens junctions of Schwann cells. We validate aTcat immunodetection specificity using a new Ctnna3-knockout fluorescence reporter mouse line yet find no obvious Schwann cell loss-of-function morphology at the light microscopic level. CTNNA3/Ctnna3 mRNA is also abundantly detected in oligodendrocytes of the central nervous system via public databases, supporting a general role for aTcat in these unique cell-cell junctions. These data suggest that the wide range of diseases linked to CTNNA3 may be through its role in maintaining neuroglial functions of central and peripheral nervous systems.
Keyphrases
- single cell
- multiple sclerosis
- cell therapy
- single molecule
- healthcare
- cell proliferation
- epithelial mesenchymal transition
- emergency department
- peripheral nerve
- autism spectrum disorder
- mental health
- gene expression
- big data
- spinal cord injury
- atrial fibrillation
- cell death
- binding protein
- left ventricular
- white matter
- cell cycle arrest
- crispr cas
- neuropathic pain
- signaling pathway
- cystic fibrosis
- chemotherapy induced
- dna methylation
- pi k akt
- electronic health record
- energy transfer